Financials data is unavailable for this security.
View more
Year on year Cocrystal Pharma Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 38.84m to a smaller loss of 17.98m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -61.98% |
---|---|
Return on equity | -68.86% |
Return on investment | -66.88% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Cocrystal Pharma Inc fell by 10.79m. Cash Flow from Financing totalled 3.99m or -- of revenues. In addition the company used 14.67m for operations while cash used for investing totalled 118.00k.
Cash flow per share | -1.74 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.71 |
---|---|
Tangible book value per share | 1.71 |
More ▼
Balance sheet in USDView more
Current ratio | 7.41 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼